
Invesco India Pharma and Healthcare Fund - Regular (G)
Equity · Sectoral
0.00%
Last 1 year
- Exit Load
- 0.50%
- Expense Ratio
- 5.19%
- Min. AmountMin. SIP Amount
- ₹100
- Min. Lump SumMin. Lump sum
- ₹1,000
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹9,00,000
- IRR
- 0.000%
- Absolute Gain
- +₹0 (+0.0%)
Returns & Rankings
Category: Equity Sectoral


63 ProductsEquity Sectoral Funds


63 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- Alpha
- -4.73
Holding Analysis
Equity/Debt/Cash Split
- Equity97%
- Debt3%
Market Cap Weightage
- Mid Cap41.1%
- Large Cap30.6%
- Small Cap25.4%
- Others3%
Sector allocation
- Healthcare97%
- Debt3%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Apollo Hospitals | Healthcare | 9.08% |
| Divi's Lab. | Pharmaceuticals | 8.74% |
| Max Healthcare | Healthcare | 8.59% |
| Sai Life | Pharmaceuticals | 8.49% |
| Sun Pharma.Inds. | Pharmaceuticals | 8.31% |
| Manipal Health | Healthcare | 7.97% |
| Dr Agarwal's Hea | Healthcare | 7.93% |
| Sahajanand Medi | Healthcare | 7.31% |
| Global Health | Healthcare | 5.96% |
| Corona Remedies | Pharmaceuticals | 5.76% |
- 9.08%
Apollo Hospitals
Healthcare
- 8.74%
Divi's Lab.
Pharmaceuticals
- 8.59%
Max Healthcare
Healthcare
- 8.49%
Sai Life
Pharmaceuticals
- 8.31%
Sun Pharma.Inds.
Pharmaceuticals
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 16.23% | 29.6% | |
| — | Equity | 28.41% | 28.89% | |
| — | Equity | 23.71% | 23.26% | |
| — | Equity | 20.06% | 21.85% | |
| — | Equity | 24.28% | 21.75% |
Peer Comparison
Invesco India Pharma and Healthcare Fund - Regular (G)
- 1 Y Return
- —
- 3 Y Return
- —
- 5 Y Return
- —
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Management

Taher Badshah
January 10, 2017 - till date Invesco Asset Management (India) Pvt. Ltd. June 22, 2010 - December 9, 2016 Senior Vice President and Head of Equities - Motilal Oswal Asset Management Company Ltd. May 2007 - May 2010 Fund Manager - Kotak Investment Advisors Ltd. September 2005 - March 2007 Fund Manager - PMS - ICICI Prudential Asset Management Company Ltd.
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- -4.73
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 0.19
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.00
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 0.00
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- -0.28
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 65.37
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
The expense ratio of Invesco India Pharma and Healthcare Fund - Regular – Regular Plan - Growth is 5.19%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
Invesco India Pharma and Healthcare Fund - Regular is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in Invesco India Pharma and Healthcare Fund - Regular with ₹100 a month, or invest a lump sum of ₹1,000. Additional investments start at ₹1,000.
Invesco India Pharma and Healthcare Fund - Regular charges an exit load of 0.5% if redeemed within 3 months of investment. The exit load is deducted from the redemption amount.
No, Invesco India Pharma and Healthcare Fund - Regular has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
Invesco India Pharma and Healthcare Fund - Regular manages assets (AUM) of approximately ₹476 Cr.
As on 31 Oct 2026, Invesco India Pharma and Healthcare Fund - Regular holds 17 securities. These are its top 10 holdings:
Company % of portfolio Apollo Hospitals 9.08% Divi's Lab. 8.74% Max Healthcare 8.59% Sai Life 8.49% Sun Pharma.Inds. 8.31% Manipal Health 7.97% Dr Agarwal's Hea 7.93% Sahajanand Medi 7.31% Global Health 5.96% Corona Remedies 5.76% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 97.04% Debt 2.96% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the Invesco Mutual Fund website, MF Central or the fund's registrar (RTA). The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.












